Please use this identifier to cite or link to this item:
|Title:||Glargine as a basal insulin supplement in recovering critically ill patients - An in silico study||Authors:||Razak, N.N.
Le Compte, A.
|Issue Date:||2010||Abstract:||Tight glycaemic control is now benefiting medical and surgical intensive care patients by reducing complications associated with hyperglycaemia. Once patients leave this intensive care environment, less acute wards do not continue to provide the same level of glycaemic control. Main reason is that these less acute wards do not have the high levels of nursing resources to provide the same level of glycaemic control. Therefore developments in protocols that are less labour intensive are necessary. This study examines the use of insulin glargine for basal supplement in recovering critically ill patients. These patients represent a group who may benefit from such basal support therapy. In silico study results showed the potential in reducing nursing effort with the use of glargine. However, a protocol using only glargine for glucose control did not show to be effective in the simulated patients. This may be an indication that a protocol using only glargine is more suitable after discharge from critical care.||URI:||http://dspace.uniten.edu.my/jspui/handle/123456789/9574|
|Appears in Collections:||COE Scholarly Publication|
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.